APRI - Apricus Biosciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue5,7634,8399,259
Cost of Revenue3,891922918
Gross Profit1,8723,9178,341
Operating Expenses
Research Development6,83114,64921,288
Selling General and Administrative8,43410,5169,662
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-13,407-21,350-22,559
Income from Continuing Operations
Total Other Income/Expenses Net6,9823,120471
Earnings Before Interest and Taxes-6,411-18,128-22,138
Interest Expense1,022895339
Income Before Tax-7,433-19,023-22,477
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-7,433-19,023-22,477
Non-recurring Events
Discontinued Operations--691
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-7,433-19,023-21,786
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-7,433-19,023-21,786